Furthermore, the pharmacology from the Lively factors was mostly uncharacterized, and confirmation of SCB use was hindered by an absence of identified biomarkers. These understanding gaps prompted experts across numerous disciplines to swiftly (1) monitor, recognize and quantify with chromatography/mass spectrometry the at any time-switching conten